Virtual Substance Use Disorders: A Comprehensive Review and Update 2026

February 6, 2026 to February 7, 2026

Overview

We invite you to join us Virtually for our Substance Use Disorders: A Comprehensive Review and Update 2026 Conference!

 

Please Note: The conference will be held in Eastern Daylight Time (EDT)

Attend this conference virtually on substance use disorders to hear the latest research and find guidance that enhances your care for patients.

Substance use disorders are complex and have a huge impact on patients, families, and communities They challenge even experienced health care professionals to stay current with evolving guidelines. They are seen and treated across all professions, disciplines, and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more.

That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.

You will receive email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the Zoom instructions and attending virtually. 


Pricing

MDs/Doctoral-Level Professionals:
Super Early Bird Registration (before October 14, 2025): $695
Early Bird Registration (before December 2, 2025): $795
Regular Registration (after December 2, 2025): $895

Other Professionals or Trainees:
Super Early Bird Registration (before October 14, 2025): $595
Early Bird Registration (before December 2, 2025): $695
Regular Registration (after December 2, 2025): $795


E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 


Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by January 1, 2026. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.


Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition

Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.

Purchase a print copy of our Board Preparation book here!

Target Audience

This program is intended for:

  • General and Family Physicians
  • Psychiatrists
  • Nurse Practitioners 
  • Physician Assistants
  • Nurses
  • Psychologists
  • Social Workers

Learning Objectives

Please come back later for this information.


Accreditation:

Please come back later for this information.

Course summary
Registration opens: 
02/17/2024
Course closes: 
02/19/2026
Event starts: 
02/06/2026 - 12:00am EST
Event ends: 
02/07/2026 - 11:59pm EST
Cost:
$1,095.00
Rating: 
0

Program

Substance Use Disorders: A Comprehensive Review and Update

February 6-7, 2026

FRIDAY, FEBRUARY 6, 2026

8:00 – 8:05 AM              Welcome & Introduction

David H. Rubin, MD

MODULE TOPIC 1: NEUROSCIENCE

8:05 – 8:25 AM              Neurobiology of Addiction & Genetics of Substance Use Disorders     

Robert R. Althoff, MD, PhD

MODULE TOPIC 2: ADOLESCENT SUBSTANCE USE  

8:25– 8:45 AM                Adolescent Substance Use Disorders

Aaron Quiggle, MD

8:45 – 9:05 AM              ADHD                                    

                                       Timothy Wilens, MD

9:05 – 9:25 AM              Athletes and Substance Use Disorders            

                                    Timothy Wilens, MD

9:25 – 9:55 AM              Panel Discussion        

Moderator: David H. Rubin, MD

Panelists: Robert R. Althoff, MD, PhD, Timothy E. Wilens, MD;

Aaron Quiggle, MD

9:55 – 10:05 AM            Break

MODULE TOPIC 3: ADVOCACY & BENZODIAZEPINES  

10:05 – 10:25 AM           Advocacy and Regulatory Updates                 

Laura G. Kehoe, MD, MPH, FASAM

10:25 – 10:45 AM           Benzodiazepines & Addiction                        

Timothy Wilens, MD

10:45 – 11:15 AM           Panel Discussion                                                        

Moderator: Timothy E. Wilens, MD

Panelists: Laura G. Kehoe, MD, MPH, FASAM

11:15 – 12:15 PM            Lunch Break

MODULE TOPIC 4: OPIOIDS

12:15 – 12:35 PM           Buprenorphine 101                  

Meredith Morrison, NP

12:35 – 12:55 PM           Long Acting Injectable Buprenorphine

  Laura Kehoe, MD, MPH, FASAM

12:55 – 1:15 PM             Naltrexone Intramuscular      

Jessica Gray, MD

1:15 – 1:35 PM               Methadone

  Laura Kehoe, MD, MPH, FASAM

1:35 – 1:45 PM               Break

1:45 – 2:15 PM               Panel Discussion

Moderator: Laura G. Kehoe, MD, MPH, FASAM

Panelist: Jessica Gray, MD, and Meredith Morrison, NP

MODULE TOPIC 5: PAIN, WOMEN & ADDICTION

2:15 – 2:35 PM              Pain

                                      TBA

2:35 – 2:55 PM              Pregnancy                   

                                    Jessica Gray, MD

2:55 – 3:15 PM              Women & Addiction

                                    Davida Schiff, MD

3:15 – 3:35 PM               Panel Discussion

Moderator: Jessica Gray, MD

Panelists: Greg Acampora, MD; Davida Schiff, MD

4:25 PM                         Adjourn


SATURDAY, FEBRUARY 7, 2026

8:00 – 8:05 AM              Welcome & Introduction

                                    John Kelly, PhD

MODULE TOPIC 6: TREATMENT IN CONTINUING CARE

8:05 – 8:25 AM              Motivational Interviewing

James McKowan, MD

8:25 – 8:45 AM              CBT                                          

James McKowan, MD

8:45 – 9:05 AM              DBT & Other Therapies

James McKowan, MD

9:05 – 9:35 AM             Panel Discussion

Moderator: John Kelly, PhD
             Panelists: James McKowan, MD

9:35 – 9:45 AM             Break

MODULE TOPIC 7: PSYCHEDELICS

9:45 – 10:05 AM            Psychedelics                             

                                    Joji Suzuki, MD

MODULE TOPIC 8: CANNABIS

10:05 – 10:25 AM          Cannabis                                 

                                    Jodi Gilman, PhD

MODULE TOPIC 9: COMORBIDITY I – SUBSTANCE USE, TRAUMA AND SEX TRAFFICKING

10:25 – 10:45 AM          Trauma                       

                                    Toby Lynch, PhD

10:45 – 11:05 AM           Sex Trafficking                        

                                    Abigail Judge, PhD

11:05 – 11:35 AM           Panel Discussion                                

Moderator: Justin Alves, RN, MSN, ACRN, CARN, CNE

Panelists: Abigail Judge, PhD; Toby Lynch, PhD; Jodi Gilman, PhD; Joji Suzuki, MD

11:35 – 12:35 PM           Lunch Break

MODULE TOPIC 10: NICOTINE  & STIMULANTS

12:35 – 12:55 PM           Cocaine & Methamphetamine

   Justin Alves, RN, MSN, ACRN, CARN, CNE

12:55 – 1:15 PM              Nicotine

  A. Eden Evins, MD

1:15 – 1:45 PM               Panel Discussion

Moderator: John Kelly, PhD

Panelists: Justin Alves, RN, MSN, ACRN, CARN, CNE; A. Eden Evins, MD

MODULE TOPIC 11: RECOVERY SUPPORT SERVICES

1:45 – 2:05 PM              Addressing and Overcoming Stigma & Discrimination in Clinical Settings

                                      John Kelly, PhD

2:05 – 2:25 PM              Peer Support and Residential Communities

  David Eddie, PhD

2:25 – 2:45 PM              Efficacy of Self-Help Treatments

  John Kelly, PhD

2:45 – 3:05 PM              Amplifying and Extending the Effects of Clinical Care

  John Kelly, PhD

3:05 – 3:35 PM             Panel Discussion                                                        

Moderator: John Kelly, PhD      
Panelist: John Kelly, PhD; David Eddie, PhD

3:35 – 3:45 PM              Break

MODULE TOPIC 12: ALCOHOL & COMORBIDITY

3:45 – 4:05 PM              Alcohol: Assessment and Maintenance Medications

Vinod Rao, MD, PhD

4:05 – 4:25 PM               Inpatient & Outpatient Medically Managed Withdrawal

Evan Gale, MD

4:25 – 4:45 PM              Anxiety & Mood

 Vinod Rao, MD, PhD

4:45 – 5:15 PM              Panel Discussion

Moderator: Vinod Rao, MD, PhD

Panelist: Evan Gale, MD

5:15 PM                          Adjourn

Faculty

Please come back later for this information.

Register/Take course

Price

Cost:
$1,095.00
Please login or register to take this course.